{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:05:08Z","timestamp":1792587908119,"version":"4.5.0"},"reference-count":112,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>\n                    Dengue is the most rapidly emerging mosquito-borne infection and, due to climate change and unplanned urbanization, it is predicted that the global burden of dengue will rise further as the infection spreads to new geographical locations. Dengue-endemic countries are often unable to cope with such increases, with health care facilities becoming overwhelmed during each dengue season. Furthermore, although dengue has been predominantly a childhood illness in the past, it currently mostly affects adults in many countries, with higher incidence of severe disease and mortality rates in pregnant women and in those with comorbidities. As there is currently no specific treatment for dengue and no early biomarker to identify those who will progress to develop vascular leakage, all individuals with dengue are closely monitored in case they need fluid management. Furthermore, diagnosing patients with acute dengue is challenging due to the similarity of clinical symptoms during early illness and poor sensitivity and specificity of point-of-care diagnostic tests. Novel vector control methods, such as the release of\n                    <jats:italic>Wolbachia-<\/jats:italic>\n                    infected mosquitoes, have shown promising results by reducing vector density and dengue incidence in clinical trial settings. A new dengue vaccine, TAK-003, had an efficacy of 61.2% against virologically confirmed dengue, 84.1% efficacy against hospitalizations and a 70% efficacy against development of dengue haemorrhagic fever (DHF) at 54 months. While vaccines and mosquito control methods are welcome, they alone are unlikely to fully reduce the burden of dengue, and a treatment for dengue is therefore essential. Several novel antiviral drugs are currently being evaluated along with drugs that inhibit host mediators, such as mast cell products. Although viral proteins such as NS1 contribute to the vascular leak observed in severe dengue, the host immune response to the viral infection also plays a significant role in progression to severe disease. There is an urgent need to discover safe and effective treatments for dengue to prevent disease progression.\n                  <\/jats:p>","DOI":"10.1371\/journal.pgph.0002598","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T13:21:11Z","timestamp":1702646471000},"page":"e0002598","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":82,"title":["Facing the escalating burden of dengue: Challenges and perspectives"],"prefix":"10.1371","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-0449","authenticated-orcid":true,"given":"Gathsaurie Neelika","family":"Malavige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6768-0536","authenticated-orcid":true,"given":"Peter","family":"Sj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Piedagnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mowbray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Estani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Chee Loon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre M.","family":"Siquierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-045X","authenticated-orcid":true,"given":"Graham S.","family":"Ogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1530-3894","authenticated-orcid":true,"given":"Laurent","family":"Fraisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"pgph.0002598.ref001","volume-title":"Ten threats to global health in 2019 [Internet].","year":"2019"},{"issue":"7","key":"pgph.0002598.ref002","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S2542-5196(21)00132-7","article-title":"Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study","volume":"5","author":"FJ Colon-Gonzalez","year":"2021","journal-title":"Lancet Planet Health"},{"key":"pgph.0002598.ref003","doi-asserted-by":"crossref","first-page":"100712","DOI":"10.1016\/j.eclinm.2020.100712","article-title":"Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017.","volume":"32","author":"Z Zeng","year":"2021","journal-title":"EClinicalMedicine."},{"issue":"9","key":"pgph.0002598.ref004","doi-asserted-by":"crossref","first-page":"e0009631","DOI":"10.1371\/journal.pntd.0009631","article-title":"The role of urbanisation in the spread of Aedes mosquitoes and the diseases they transmit-A systematic review.","volume":"15","author":"A Kolimenakis","year":"2021","journal-title":"PLoS neglected tropical diseases."},{"issue":"12","key":"pgph.0002598.ref005","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/JCM.00707-17","article-title":"Progress and Challenges towards Point-of-Care Diagnostic Development for Dengue","volume":"55","author":"J Pang","year":"2017","journal-title":"Journal of clinical microbiology"},{"issue":"3","key":"pgph.0002598.ref006","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/S2214-109X(22)00547-2","article-title":"Differentiating dengue from other febrile illnesses: a dilemma faced by clinicians in dengue endemic countries","volume":"11","author":"GN Malavige","year":"2023","journal-title":"Lancet Glob Health"},{"key":"pgph.0002598.ref007","year":"2022","journal-title":"Coronavirus Pandemic (COVID-19) [Internet]."},{"issue":"7","key":"pgph.0002598.ref008","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1002\/jmv.26955","article-title":"Dengue and COVID-19: A double burden to Brazil","volume":"93","author":"AT Rabiu","year":"2021","journal-title":"Journal of medical virology"},{"issue":"2","key":"pgph.0002598.ref009","doi-asserted-by":"crossref","first-page":"e2161","DOI":"10.1002\/rmv.2161","article-title":"Covid-19 and dengue: Double punches for dengue-endemic countries in Asia","volume":"31","author":"H Harapan","year":"2021","journal-title":"Reviews in medical virology"},{"key":"pgph.0002598.ref010","article-title":"Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity.","author":"PV Markov","year":"2022","journal-title":"Nature reviews."},{"issue":"7446","key":"pgph.0002598.ref011","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"S Bhatt","year":"2013","journal-title":"Nature"},{"key":"pgph.0002598.ref012","volume-title":"Geographical expansion of cases of dengue and chikungunya beyond the historical areas of transmission in the Region of the Americas [Internet]","year":"2023"},{"key":"pgph.0002598.ref013","volume-title":"Epidemiological Update for Dengue, Chikungunya and Zika in 2022.","author":"PAHO","year":"2022"},{"issue":"12","key":"pgph.0002598.ref014","doi-asserted-by":"crossref","first-page":"e0005194","DOI":"10.1371\/journal.pntd.0005194","article-title":"Dengue in the Middle East and North Africa: A Systematic Review.","volume":"10","author":"JM Humphrey","year":"2016","journal-title":"PLoS neglected tropical diseases."},{"issue":"1","key":"pgph.0002598.ref015","doi-asserted-by":"crossref","first-page":"13626","DOI":"10.1038\/s41598-019-50135-x","article-title":"Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies.","volume":"9","author":"FBN Simo","year":"2019","journal-title":"Sci Rep."},{"issue":"8","key":"pgph.0002598.ref016","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1473-3099(16)00146-8","article-title":"The global economic burden of dengue: a systematic analysis","volume":"16","author":"DS Shepard","year":"2016","journal-title":"The Lancet infectious diseases"},{"issue":"11","key":"pgph.0002598.ref017","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1089\/vbz.2013.1528","article-title":"An estimate of the global health care and lost productivity costs of dengue.","volume":"14","author":"FW Selck","year":"2014","journal-title":"Vector borne and zoonotic diseases (Larchmont, NY."},{"key":"pgph.0002598.ref018","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijid.2019.01.010","article-title":"Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis","volume":"84S","author":"D Hariharan","year":"2019","journal-title":"Int J Infect Dis"},{"key":"pgph.0002598.ref019","article-title":"Epidemiology (2012\u20132019) and costs (2009\u20132019) of dengue in Malaysia: a systematic literature review.","author":"S AbuBakar","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"pgph.0002598.ref020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1179\/2047773214Y.0000000168","article-title":"Is dengue a disease of poverty? A systematic review.","volume":"109","author":"K Mulligan","year":"2015","journal-title":"Pathogens and global health."},{"issue":"8","key":"pgph.0002598.ref021","doi-asserted-by":"crossref","first-page":"e0009624","DOI":"10.1371\/journal.pntd.0009624","article-title":"Changing epidemiology of dengue in Sri Lanka-Challenges for the future.","volume":"15","author":"GN Malavige","year":"2021","journal-title":"PLoS neglected tropical diseases."},{"issue":"20","key":"pgph.0002598.ref022","doi-asserted-by":"crossref","first-page":"e2115790119","DOI":"10.1073\/pnas.2115790119","article-title":"Assessing the role of multiple mechanisms increasing the age of dengue cases in Thailand","volume":"119","author":"AT Huang","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"pgph.0002598.ref023","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/1471-2334-14-412","article-title":"The changing incidence of dengue haemorrhagic fever in Indonesia: a 45-year registry-based analysis.","volume":"14","author":"MR Karyanti","year":"2014","journal-title":"BMC infectious diseases."},{"issue":"6","key":"pgph.0002598.ref024","doi-asserted-by":"crossref","first-page":"e0011400","DOI":"10.1371\/journal.pntd.0011400","article-title":"Singapore\u2019s 5 decades of dengue prevention and control-Implications for global dengue control.","volume":"17","author":"SH Ho","year":"2023","journal-title":"PLoS neglected tropical diseases."},{"issue":"7","key":"pgph.0002598.ref025","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S1473-3099(20)30601-0","article-title":"Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis","volume":"21","author":"S Sangkaew","year":"2021","journal-title":"The Lancet infectious diseases"},{"key":"pgph.0002598.ref026","article-title":"Diabetic patients suffering dengue are at risk for development of dengue shock syndrome\/severe dengue: Emphasizing the impacts of co-existing comorbidity(ies) and glycemic control on dengue severity.","author":"IK Lee","year":"2018","journal-title":"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi."},{"key":"pgph.0002598.ref027","first-page":"2023.09.14.23295528","article-title":"Are the rise in childhood obesity rates leading an increase in hospitalizations due to dengue?","author":"C Jeewandara","year":"2023","journal-title":"medRxiv"},{"issue":"12","key":"pgph.0002598.ref028","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S2213-8587(20)30370-3","article-title":"Metabolic health in Brazil: trends and challenges","volume":"8","author":"RV Cohen","year":"2020","journal-title":"The lancet Diabetes & endocrinology"},{"issue":"1","key":"pgph.0002598.ref029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12889-017-4041-1","article-title":"Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review.","volume":"17","author":"P Ranasinghe","year":"2017","journal-title":"BMC public health."},{"issue":"4","key":"pgph.0002598.ref030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4269\/ajtmh.13-0197","article-title":"Identification of concurrent bacterial infection in adult patients with dengue","volume":"89","author":"KC See","year":"2013","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"12","key":"pgph.0002598.ref031","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1099\/jmm.0.000388","article-title":"The exploration of risk factors of concurrent bacteraemia in patients critically ill with severe dengue","volume":"65","author":"CM Chen","year":"2016","journal-title":"Journal of medical microbiology"},{"issue":"1","key":"pgph.0002598.ref032","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1038\/s41598-018-28387-w","article-title":"Dengue in pregnancy and maternal mortality: a cohort analysis using routine data.","volume":"8","author":"ES Paixao","year":"2018","journal-title":"Sci Rep."},{"issue":"1","key":"pgph.0002598.ref033","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00404-020-05930-7","article-title":"Maternal and fetal outcomes of dengue fever in pregnancy: a large prospective and descriptive observational study","volume":"304","author":"R Brar","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"pgph.0002598.ref034","volume-title":"National Guidelines for the Clinical Management of Dengue Infection in Pregnancy","author":"Ministry of Health SL","year":"2019"},{"key":"pgph.0002598.ref035","author":"L. Martin FKM","year":"2023","journal-title":"Maternal Dengue and Health Outcomes of Children American Economic Journal: Applied Economics"},{"issue":"3","key":"pgph.0002598.ref036","doi-asserted-by":"crossref","first-page":"e0007213","DOI":"10.1371\/journal.pntd.0007213","article-title":"Global expansion and redistribution of Aedes-borne virus transmission risk with climate change.","volume":"13","author":"SJ Ryan","year":"2019","journal-title":"PLoS neglected tropical diseases."},{"key":"pgph.0002598.ref037","doi-asserted-by":"crossref","first-page":"584846","DOI":"10.3389\/fmicb.2020.584846","article-title":"The Role of Temperature in Shaping Mosquito-Borne Viruses Transmission.","volume":"11","author":"R Bellone","year":"2020","journal-title":"Front Microbiol."},{"issue":"10","key":"pgph.0002598.ref038","doi-asserted-by":"crossref","first-page":"e2003489","DOI":"10.1371\/journal.pbio.2003489","article-title":"Quantifying the effects of temperature on mosquito and parasite traits that determine the transmission potential of human malaria","volume":"15","author":"LLM Shapiro","year":"2017","journal-title":"PLoS Biol"},{"key":"pgph.0002598.ref039","doi-asserted-by":"crossref","first-page":"100382","DOI":"10.1016\/j.epidem.2019.100382","article-title":"Temperature-dependent variation in the extrinsic incubation period elevates the risk of vector-borne disease emergence.","volume":"30","author":"T Kamiya","year":"2019","journal-title":"Epidemics"},{"key":"pgph.0002598.ref040","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3389\/fmicb.2017.02337","article-title":"Temperature Increase Enhances Aedes albopictus Competence to Transmit Dengue Virus.","volume":"8","author":"Z Liu","year":"2017","journal-title":"Front Microbiol."},{"issue":"1","key":"pgph.0002598.ref041","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1038\/s41598-022-10977-4","article-title":"Impact of temperature on dengue and chikungunya transmission by the mosquito Aedes albopictus.","volume":"12","author":"A Mercier","year":"2022","journal-title":"Sci Rep."},{"issue":"8","key":"pgph.0002598.ref042","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1179\/2047773212Y.0000000060","article-title":"Community mobilization and household level waste management for dengue vector control in Gampaha district of Sri Lanka; an intervention study.","volume":"106","author":"W Abeyewickreme","year":"2012","journal-title":"Pathogens and global health"},{"issue":"10","key":"pgph.0002598.ref043","doi-asserted-by":"crossref","first-page":"e0138082","DOI":"10.1371\/journal.pone.0138082","article-title":"Household Wastes as Larval Habitats of Dengue Vectors: Comparison between Urban and Rural Areas of Kolkata, India.","volume":"10","author":"S Banerjee","year":"2015","journal-title":"PloS one."},{"issue":"1","key":"pgph.0002598.ref044","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41598-019-56766-4","article-title":"Aedes aegypti insecticide resistance underlies the success (and failure) of Wolbachia population replacement.","volume":"10","author":"GA Garcia","year":"2020","journal-title":"Sci Rep."},{"issue":"6","key":"pgph.0002598.ref045","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S2214-109X(16)00082-6","article-title":"Alternative vector control methods to manage the Zika virus outbreak: more haste, less speed","volume":"4","author":"J Bouyer","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"23","key":"pgph.0002598.ref046","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1056\/NEJMoa2030243","article-title":"Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue","volume":"384","author":"A Utarini","year":"2021","journal-title":"The New England journal of medicine"},{"issue":"26","key":"pgph.0002598.ref047","doi-asserted-by":"crossref","first-page":"e2118283119","DOI":"10.1073\/pnas.2118283119","article-title":"Efficacy of a spatial repellent for control of Aedes-borne virus transmission: A cluster-randomized trial in Iquitos, Peru","volume":"119","author":"AC Morrison","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"pgph.0002598.ref048","doi-asserted-by":"crossref","first-page":"e1008433","DOI":"10.1371\/journal.ppat.1008433","article-title":"Multiple Wolbachia strains provide comparative levels of protection against dengue virus infection in Aedes aegypti.","volume":"16","author":"HA Flores","year":"2020","journal-title":"PLoS pathogens."},{"key":"pgph.0002598.ref049","doi-asserted-by":"crossref","first-page":"626329","DOI":"10.3389\/fimmu.2020.626329","article-title":"The Antiviral Effects of the Symbiont Bacteria Wolbachia in Insects.","volume":"11","author":"AC Pimentel","year":"2020","journal-title":"Frontiers in immunology"},{"issue":"13","key":"pgph.0002598.ref050","doi-asserted-by":"crossref","first-page":"e0220320","DOI":"10.1128\/JVI.02203-20","article-title":"Using Wolbachia to Eliminate Dengue: Will the Virus Fight Back?","volume":"95","author":"KM Edenborough","year":"2021","journal-title":"Journal of virology"},{"issue":"1","key":"pgph.0002598.ref051","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13063-022-06998-z","article-title":"A cluster-randomized, placebo-controlled trial to evaluate the efficacy of a spatial repellent (Mosquito Shield) against Aedes-borne virus infection among children >\/ = 4\u201316 years of age in the Gampaha District, Sri Lanka: study protocol (the AEGIS program).","volume":"24","author":"H Tissera","year":"2023","journal-title":"Trials"},{"key":"pgph.0002598.ref052","volume-title":"Comprehensive guidelines for prevention and control of dengue fever and dengue haemorrhagic fever","author":"WHO","year":"2011"},{"issue":"5","key":"pgph.0002598.ref053","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/infdis\/jiw220","article-title":"Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational Study","volume":"214","author":"S Yacoub","year":"2016","journal-title":"The Journal of infectious diseases"},{"key":"pgph.0002598.ref054","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67460","article-title":"Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes.","volume":"10","author":"NL Vuong","year":"2021","journal-title":"Elife"},{"key":"pgph.0002598.ref055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-981-10-8727-1_5","article-title":"The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections","volume":"1062","author":"EN Gallichotte","year":"2018","journal-title":"Advances in experimental medicine and biology"},{"issue":"6365","key":"pgph.0002598.ref056","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"LC Katzelnick","year":"2017","journal-title":"Science"},{"key":"pgph.0002598.ref057","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fimmu.2014.00280","article-title":"Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections","volume":"5","author":"L Grange","year":"2014","journal-title":"Frontiers in immunology"},{"issue":"1","key":"pgph.0002598.ref058","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00705-021-05298-2","article-title":"Mammalian animal models for dengue virus infection: a recent overview","volume":"167","author":"MEH Kayesh","year":"2022","journal-title":"Archives of virology"},{"key":"pgph.0002598.ref059","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2020.09.001","article-title":"Dengue mouse models for evaluating pathogenesis and countermeasures","volume":"43","author":"RE Chen","year":"2020","journal-title":"Current opinion in virology"},{"issue":"1","key":"pgph.0002598.ref060","article-title":"Humanized Mice in Dengue Research: A Comparison with Other Mouse Models.","volume":"8","author":"C Coronel-Ruiz","year":"2020","journal-title":"Vaccines (Basel)."},{"issue":"7","key":"pgph.0002598.ref061","first-page":"532","article-title":"Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health","volume":"9","author":"N Vasilakis","year":"2011","journal-title":"Nature reviews"},{"issue":"4","key":"pgph.0002598.ref062","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9040247","article-title":"Non-Human Primate Models of Dengue Virus Infection: A Comparison of Viremia Levels and Antibody Responses during Primary and Secondary Infection among Old World and New World Monkeys.","volume":"9","author":"NA Muhammad Azami","year":"2020","journal-title":"Pathogens"},{"key":"pgph.0002598.ref063","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2020.09.004","article-title":"Dengue vaccine development by the year 2020: challenges and prospects","volume":"43","author":"A. Wilder-Smith","year":"2020","journal-title":"Current opinion in virology."},{"issue":"1","key":"pgph.0002598.ref064","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41467-018-06006-6","article-title":"Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning","volume":"9","author":"I Dorigatti","year":"2018","journal-title":"Nat Commun"},{"key":"pgph.0002598.ref065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65131","article-title":"Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level phase III data","volume":"10","author":"DJ Laydon","year":"2021","journal-title":"Elife"},{"issue":"1","key":"pgph.0002598.ref066","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/ciab864","article-title":"Three-year Efficacy and Safety of Takeda\u2019s Dengue Vaccine Candidate (TAK-003).","volume":"75","author":"L Rivera","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"13","key":"pgph.0002598.ref067","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease","volume":"373","author":"SR Hadinegoro","year":"2015","journal-title":"The New England journal of medicine"},{"key":"pgph.0002598.ref068","article-title":"Takeda","year":"2022","journal-title":"Takeda\u2019s QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure: Takeda Pharmaceutical Company Limited"},{"key":"pgph.0002598.ref069","year":"2022","journal-title":"Takeda\u2019s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial [Internet]."},{"key":"pgph.0002598.ref070","article-title":"Highlights from the Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization [Internet].","year":"2023","journal-title":"WHO Strategic Advisory Group of Experts (SAGE) on Immunization;"},{"issue":"5","key":"pgph.0002598.ref071","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nbt0516-449","article-title":"NIH dengue vaccine leaps into phase 3 studies","volume":"34","author":"JM Perkel","year":"2016","journal-title":"Nature biotechnology"},{"issue":"330","key":"pgph.0002598.ref072","doi-asserted-by":"crossref","first-page":"330ra36","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"BD Kirkpatrick","year":"2016","journal-title":"Science translational medicine"},{"key":"pgph.0002598.ref073","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.jvacx.2022.100142","article-title":"Safety and immunogenicity of a single dose, live-attenuated \u2019tetravalent dengue vaccine\u2019 in healthy Indian adults; a randomized, double-blind, placebo controlled phase I\/II trial.","volume":"10","author":"L Mohanty","year":"2022","journal-title":"Vaccine X"},{"issue":"1","key":"pgph.0002598.ref074","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41467-021-21384-0","article-title":"A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans","volume":"12","author":"UK Nivarthi","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"pgph.0002598.ref075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-023-00658-2","article-title":"Is new dengue vaccine efficacy data a relief or cause for concern?","volume":"8","author":"SJ Thomas","year":"2023","journal-title":"NPJ Vaccines."},{"issue":"23","key":"pgph.0002598.ref076","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","article-title":"Nextstrain: real-time tracking of pathogen evolution","volume":"34","author":"J Hadfield","year":"2018","journal-title":"Bioinformatics"},{"key":"pgph.0002598.ref077","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-0-387-73960-1_10","article-title":"Management of severe dengue in children","volume":"609","author":"C Moxon","year":"2008","journal-title":"Advances in experimental medicine and biology"},{"issue":"9","key":"pgph.0002598.ref078","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa044057","article-title":"Comparison of three fluid solutions for resuscitation in dengue shock syndrome","volume":"353","author":"BA Wills","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"1","key":"pgph.0002598.ref079","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12879-021-05971-6","article-title":"Fluid requirement in adult dengue haemorrhagic fever patients during the critical phase of the illness: an observational study.","volume":"21","author":"P Madanayake","year":"2021","journal-title":"BMC infectious diseases."},{"key":"pgph.0002598.ref080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2020.07.009","article-title":"Recent advances in antiviral drug development towards dengue virus","volume":"43","author":"B Troost","year":"2020","journal-title":"Current opinion in virology"},{"issue":"4","key":"pgph.0002598.ref081","first-page":"468","article-title":"Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"62","author":"J Whitehorn","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pgph.0002598.ref082","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.","volume":"14","author":"JG Low","year":"2014","journal-title":"The Lancet infectious diseases"},{"issue":"8","key":"pgph.0002598.ref083","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.","volume":"4","author":"V Tricou","year":"2010","journal-title":"PLoS neglected tropical diseases."},{"issue":"7881","key":"pgph.0002598.ref084","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","article-title":"A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction","volume":"598","author":"SJF Kaptein","year":"2021","journal-title":"Nature"},{"issue":"579","key":"pgph.0002598.ref085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb2181","article-title":"NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models","volume":"13","author":"SA Moquin","year":"2021","journal-title":"Science translational medicine"},{"issue":"11","key":"pgph.0002598.ref086","doi-asserted-by":"crossref","first-page":"e0098821","DOI":"10.1128\/AAC.00988-21","article-title":"Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses","volume":"65","author":"SS Good","year":"2021","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"pgph.0002598.ref087","volume":"2023","year":"2023","journal-title":"Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update [Internet]."},{"key":"pgph.0002598.ref088","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.antiviral.2017.05.007","article-title":"Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates","volume":"144","author":"EZ Ong","year":"2017","journal-title":"Antiviral research"},{"key":"pgph.0002598.ref089","author":"ClinicalTrials.gov","year":"2022","journal-title":"A Study to Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers"},{"issue":"1","key":"pgph.0002598.ref090","doi-asserted-by":"crossref","first-page":"12987","DOI":"10.1038\/s41598-021-92403-9","article-title":"An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency","volume":"11","author":"T Kotaki","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"pgph.0002598.ref091","doi-asserted-by":"crossref","first-page":"e1010469","DOI":"10.1371\/journal.ppat.1010469","article-title":"Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.","volume":"18","author":"SM Tien","year":"2022","journal-title":"PLoS pathogens."},{"issue":"8","key":"pgph.0002598.ref092","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.4049\/jimmunol.1601523","article-title":"Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection","volume":"199","author":"SW Wan","year":"2017","journal-title":"J Immunol"},{"issue":"2","key":"pgph.0002598.ref093","doi-asserted-by":"crossref","first-page":"e0006209","DOI":"10.1371\/journal.pntd.0006209","article-title":"Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.","volume":"12","author":"Y Budigi","year":"2018","journal-title":"PLoS neglected tropical diseases."},{"key":"pgph.0002598.ref094","first-page":"2023.07.31.23293412","article-title":"Are viral loads in the febrile phase a predictive factor of dengue disease severity?","author":"S Dayarathna","year":"2023","journal-title":"medRxiv"},{"issue":"9","key":"pgph.0002598.ref095","doi-asserted-by":"crossref","first-page":"e1309","DOI":"10.1371\/journal.pntd.0001309","article-title":"Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.","volume":"5","author":"V Tricou","year":"2011","journal-title":"PLoS neglected tropical diseases."},{"issue":"3","key":"pgph.0002598.ref096","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/imm.12748","article-title":"Pathogenesis of vascular leak in dengue virus infection","volume":"151","author":"GN Malavige","year":"2017","journal-title":"Immunology"},{"issue":"11","key":"pgph.0002598.ref097","doi-asserted-by":"crossref","first-page":"e1006673","DOI":"10.1371\/journal.ppat.1006673","article-title":"Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components.","volume":"13","author":"DR Glasner","year":"2017","journal-title":"PLoS pathogens."},{"key":"pgph.0002598.ref098","doi-asserted-by":"crossref","first-page":"590004","DOI":"10.3389\/fcimb.2020.590004","article-title":"Dysfunctional Innate Immune Responses and Severe Dengue.","volume":"10","author":"GN Malavige","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"pgph.0002598.ref099","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05291","article-title":"Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcgamma receptors","volume":"4","author":"A Syenina","year":"2015","journal-title":"Elife"},{"issue":"1","key":"pgph.0002598.ref100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s42003-022-03682-5","article-title":"Dengue virus co-opts innate type 2 pathways to escape early control of viral replication.","volume":"5","author":"CL Fonseka","year":"2022","journal-title":"Commun Biol."},{"issue":"1","key":"pgph.0002598.ref101","doi-asserted-by":"crossref","first-page":"11856","DOI":"10.1038\/s41598-020-68844-z","article-title":"Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients.","volume":"10","author":"APS Rathore","year":"2020","journal-title":"Sci Rep."},{"issue":"1","key":"pgph.0002598.ref102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/iid3.135","article-title":"Secretory phospholipase A2 in the pathogenesis of acute dengue infection.","volume":"5","author":"C Jeewandara","year":"2017","journal-title":"Immun Inflamm Dis"},{"issue":"2","key":"pgph.0002598.ref103","doi-asserted-by":"crossref","first-page":"e0245926","DOI":"10.1371\/journal.pone.0245926","article-title":"Urinary leukotrienes and histamine in patients with varying severity of acute dengue.","volume":"16","author":"T Silva","year":"2021","journal-title":"PloS one."},{"issue":"304","key":"pgph.0002598.ref104","doi-asserted-by":"crossref","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","article-title":"Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination","volume":"7","author":"PR Beatty","year":"2015","journal-title":"Science translational medicine"},{"issue":"6","key":"pgph.0002598.ref105","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism","volume":"26","author":"H Puerta-Guardo","year":"2019","journal-title":"Cell reports"},{"key":"pgph.0002598.ref106","doi-asserted-by":"crossref","first-page":"105312","DOI":"10.1016\/j.antiviral.2022.105312","article-title":"Dengue NS1 induces phospholipase A2 enzyme activity, prostaglandins, and inflammatory cytokines in monocytes","volume":"202","author":"T Silva","year":"2022","journal-title":"Antiviral research"},{"issue":"1","key":"pgph.0002598.ref107","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1038\/s41598-018-22285-x","article-title":"A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection.","volume":"8","author":"GN Malavige","year":"2018","journal-title":"Sci Rep."},{"issue":"6","key":"pgph.0002598.ref108","doi-asserted-by":"crossref","first-page":"e0010123","DOI":"10.1371\/journal.pntd.0010123","article-title":"Efficacy of rupatadine in reducing the incidence of dengue haemorrhagic fever in patients with acute dengue: A randomised, double blind, placebo-controlled trial.","volume":"16","author":"GN Malavige","year":"2022","journal-title":"PLoS neglected tropical diseases."},{"issue":"4","key":"pgph.0002598.ref109","first-page":"1115","article-title":"Montelukast Reduces the Risk of Dengue Shock Syndrome in Dengue Patients.","volume":"35","author":"A Ahmad","year":"2018","journal-title":"Tropical biomedicine"},{"issue":"18","key":"pgph.0002598.ref110","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00617-17","article-title":"Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model","volume":"91","author":"J Morrison","year":"2017","journal-title":"Journal of virology"},{"issue":"1","key":"pgph.0002598.ref111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"DW Vaughn","year":"2000","journal-title":"The Journal of infectious diseases"},{"issue":"10","key":"pgph.0002598.ref112","doi-asserted-by":"crossref","first-page":"e0010832","DOI":"10.1371\/journal.pntd.0010832","article-title":"Dengue algorithms integrated into the IMCI guidelines: An updated assessment in five Southeast-Asian countries.","volume":"16","author":"S Petzold","year":"2022","journal-title":"PLoS neglected tropical diseases."}],"updated-by":[{"DOI":"10.1371\/journal.pgph.0003499","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000}}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0002598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T13:22:04Z","timestamp":1702646524000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0002598"}},"subtitle":[],"editor":[{"given":"Giorgia","family":"Sulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":112,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0002598","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}